During the last session, Checkpoint Therapeutics Inc (NASDAQ:CKPT)’s traded shares were 0.62 million, with the beta value of the company hitting 1.52. At the end of the trading day, the stock’s price was $2.47, reflecting an intraday gain of 3.78% or $0.09. The 52-week high for the CKPT share is $4.50, that puts it down -82.19 from that peak though still a striking 44.13% gain since the share price plummeted to a 52-week low of $1.38. The company’s market capitalization is $120.61M, and the average trade volume was 1.32 million shares over the past three months.
Checkpoint Therapeutics Inc (CKPT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. CKPT has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.12.
Checkpoint Therapeutics Inc (NASDAQ:CKPT) trade information
Checkpoint Therapeutics Inc (CKPT) registered a 3.78% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 3.78% in intraday trading to $2.47, hitting a weekly high. The stock’s 5-day price performance is -13.64%, and it has moved by -33.78% in 30 days. Based on these gigs, the overall price performance for the year is 10.76%.
Checkpoint Therapeutics Inc (CKPT) estimates and forecasts
In the rating firms’ projections, revenue will decrease -86.73% compared to the previous financial year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 26.32%. While earnings are projected to return 72.34% in 2025.
CKPT Dividends
Checkpoint Therapeutics Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Also, the Mutual Funds coming in first place with the largest holdings of Checkpoint Therapeutics Inc (CKPT) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 1.09 shares. This amounts to just over 2.27 percent of the company’s overall shares, with a $2.7 million market value. The same data shows that the other fund manager holds slightly less at 265.74, or about 0.55% of the stock, which is worth about $0.66 million.
